These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological]. Mukhina LP; Kozlova NA; Rykushin IuP; Bichurina MA; Polzik TP Tr Inst Im Pastera; 1979; 52():71-5. PubMed ID: 162089 [No Abstract] [Full Text] [Related]
23. [Immunization of elderly subjects with subunit and total virus vaccine containing H1N1 influenza virus]. Masurel N Ned Tijdschr Geneeskd; 1979 Feb; 123(6):196-9. PubMed ID: 418912 [No Abstract] [Full Text] [Related]
24. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain. Sidorova LA; Alekseyeva AK Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209 [No Abstract] [Full Text] [Related]
25. Purified viral neuraminidase vaccine to control influenza. Arora DJ Can Med Assoc J; 1979 Dec; 121(12):1575-9. PubMed ID: 394829 [TBL] [Abstract][Full Text] [Related]
26. The effect of species and organ-specific features of tissue systems on the reactogenic and immunogenic properties of influenza virus. Gorev NE Acta Virol; 1975 Jan; 19(1):41-6. PubMed ID: 235196 [TBL] [Abstract][Full Text] [Related]
27. Studies with live attenuated influenza vaccines. Douglas RG; Betts RF Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888 [TBL] [Abstract][Full Text] [Related]
31. Preliminary results of oral influenza vaccination with live attenuated viruses. DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972 [TBL] [Abstract][Full Text] [Related]
32. Laboratory and clinical evaluation of new live influenza virus vaccines. Need for minimum requirements. Huygelen C Dev Biol Stand; 1977 Jun 1-3; 39():155-60. PubMed ID: 342307 [TBL] [Abstract][Full Text] [Related]
33. [Live influenza vaccine]. Smorodintsev AA Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315 [No Abstract] [Full Text] [Related]
34. [Prevention of influenza by vaccines administered intramuscularly and intradermally]. Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435 [No Abstract] [Full Text] [Related]
35. Critical considerations concerning the present state of knowledge on immunity to influenza. Cajal N; Pertrescu AL Virologie; 1980; 31(4):295-301. PubMed ID: 7257178 [No Abstract] [Full Text] [Related]
36. The control of influenza. Mostow SR Am Rev Respir Dis; 1974 Nov; 110(5):542-4. PubMed ID: 4473948 [No Abstract] [Full Text] [Related]
38. Evaluation of a temperature-sensitive influenza virus in elderly and chronically ill subjects. Douglas RG; Bentley DW; Betts RF; Zaky DA; Roth FK; Murphy BR Am Rev Respir Dis; 1976 Mar; 113(3):293-300. PubMed ID: 1259238 [TBL] [Abstract][Full Text] [Related]
39. Protective efficacy of a live, attenuated, influenza virus vaccine ('Alice' strain). Prinzie A; Delem A; Huygelen C Postgrad Med J; 1976 Jun; 52(608):395-8. PubMed ID: 785431 [TBL] [Abstract][Full Text] [Related]
40. [Genetic techniques for the production of influenza vaccines (author's transl)]. Teti G Ann Sclavo; 1980; 22(1):34-9. PubMed ID: 7018413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]